October 23, 2013
Cephalon Inc. hit competitor Eagle Pharmaceuticals Inc. with a suit Monday in a Delaware federal court alleging that Eagle is infringing a Cephalon patent by filing a new drug application for a liquid concentrate version of Cephalon's cancer drug Treanda.